Indication
Active immunisation of cattle to reduce the clinical signs of infectious bovine rhinotracheitis (IBR) and field virus excretion.The onset of immunity is 14 days and the duration of immunity is 6 months.
Loading your page…
Loading your page…
Marketing Authorisation Holder: Merial
EMA Authorisation: 09/03/2000
INN: infectious bovine rhinotracheitis vaccine (inactivated)
AI Drug & Interaction Analysis
Free account required
Ask Osler about Bovalto Ibraxion: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.